Clinical Effectiveness of Non-contact Heart Rate and Respiratory Rate Monitoring System

NCT ID: NCT06573203

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-21

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, hospitalized neonates were taken as the focus of the study. The non-contact heart rate and respiratory rate monitoring system was used to measure heart rate, respiratory rate, sleep parameters, ECG monitor, neonatal sleep-wake scale, amplitude-integrated electroencephalography. aEEG), in order to provide a theoretical basis for standardizing the operation of medical staff and formulating sleep protection strategies in the future, so as to promote the sleep quality of hospitalized neonates and improve the prognosis of neonates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The non-contact heart rate and respiratory rate monitoring system collected the body vibration signals of children through the heart rate and respiratory rate sensor, converted the pressure signals of vibration into electrical signals, extracted heart rate and respiratory rate, and extracted the characteristic parameters of sleep stages using heart rate and respiratory rate and body movement signals. It is characterized by no need to wear any equipment, the monitoring mattress is placed under the original baby mattress, no direct contact with the skin of the child, no comfort, and no change in the original sleep habits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Infant,newborn Vital Signs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-contact heart rate and respiratory rate monitoring system

After admission, the non-contact mattress is placed under a normal mattress, and heart rate, respiratory rate, and sleep-related parameters can be collected through induction.

Group Type EXPERIMENTAL

Mindray ECG monitor

Intervention Type DEVICE

Heart rate and respiratory rate of each enrolled child were monitored after admission.

aEEG

Intervention Type DEVICE

Each enrolled child underwent a 6-hour sleep-wake cycle, quiet sleep, and active sleep monitoring after admission.

Neonatal Sleep-Wake Assessment Tool (NSWAT) included four dimensions: eye movement, respiratory rate, facial expression and muscle activity.

Intervention Type OTHER

The study nurses observed and scored the children's sleep-wake status 10 minutes after two meals during the mattress test period, each time for 5 minutes.

Electrocardiogram monitor

Measuring vital signs

Group Type ACTIVE_COMPARATOR

Non-contact heart rate and respiratory rate monitoring system

Intervention Type DEVICE

Each neonate enrolled underwent four sleep and vital signs monitoring procedures after admission.

Amplitude-integrated EEG

Sleep parameters were continuously measured by aEEG for 6 hours after admission.

Group Type ACTIVE_COMPARATOR

Non-contact heart rate and respiratory rate monitoring system

Intervention Type DEVICE

Each neonate enrolled underwent four sleep and vital signs monitoring procedures after admission.

Neonatal Sleep-Wake Assessment Tool

It is suitable for all newborns to observe and evaluate the sleep phase, wake period and regularity, and guide the choice of care time. The scale includes four dimensions: eye movement, breathing rate, facial expression and muscle activity. The score range of each dimension is 0 \~ 2 points, and the score range is 0 \~ 8 points.

Group Type ACTIVE_COMPARATOR

Non-contact heart rate and respiratory rate monitoring system

Intervention Type DEVICE

Each neonate enrolled underwent four sleep and vital signs monitoring procedures after admission.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-contact heart rate and respiratory rate monitoring system

Each neonate enrolled underwent four sleep and vital signs monitoring procedures after admission.

Intervention Type DEVICE

Mindray ECG monitor

Heart rate and respiratory rate of each enrolled child were monitored after admission.

Intervention Type DEVICE

aEEG

Each enrolled child underwent a 6-hour sleep-wake cycle, quiet sleep, and active sleep monitoring after admission.

Intervention Type DEVICE

Neonatal Sleep-Wake Assessment Tool (NSWAT) included four dimensions: eye movement, respiratory rate, facial expression and muscle activity.

The study nurses observed and scored the children's sleep-wake status 10 minutes after two meals during the mattress test period, each time for 5 minutes.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

model YBB-B1 model cPM 10C model Nicolet EEG V32

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborns admitted to our hospital for the first time, with gestational age ≥28w;
* Expected hospital stay ≥5 days.

Exclusion Criteria

* Apgar score ≤3 at 1 or 5 min after birth;
* Severe congenital malformation; Severe hypoxic-ischemic encephalopathy, intraventricular hemorrhage of grade III and above; There were serious heart and lung diseases.
Minimum Eligible Age

1 Day

Maximum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jiaxing Yuanbeibei Technology Co. LTD

UNKNOWN

Sponsor Role collaborator

Children's Hospital, Zhejiang University School of Medicine

UNKNOWN

Sponsor Role collaborator

The Children's Hospital of Zhejiang University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shujun Li

Honorary Director of Nursing Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongzhen Xu

Role: PRINCIPAL_INVESTIGATOR

The Children's Hospital Affiliated to the Medical College of Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Children's Hospital Affiliated to the Medical College of Zhejiang University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-IEC-0024-P-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.